|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.085 USD | -2.11% |
|
-14.52% | -31.10% |
Esperion Therapeutics, Inc. announced that the board of directors appointed Eric Warren, R.Ph. as the Company's Chief Commercial Officer pursuant to the terms of an employment agreement with Mr. Warren, effective as of March 1, 2022. Mr. Warren has served as the Company's Vice President, US Sales and Marketing since January 2021.
Prior to joining the Company, from August 2020 to January 2021.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.10% | 40Cr | |
| +37.73% | 73TCr | |
| -7.93% | 35TCr | |
| +15.59% | 33TCr | |
| -0.50% | 28TCr | |
| +13.47% | 24TCr | |
| +7.35% | 21TCr | |
| -6.42% | 20TCr | |
| +3.90% | 16TCr | |
| -2.05% | 16TCr |
ESPERION THERAPEUTICS, INC. 
